1 Comment

While FDA approval will be a seminal event for MAPS and their MDMA protocol, an equally important event will be obtaining meaningful reimbursement for treatment from both private insurers and medicare/medicaid. That's the only path for economic sustainability for MAPS public benefit corp and therapists, who in order to to devote their careers to PAT, will need to reach a marketplace beyond private pay.

Expand full comment